Market regulator Sebi, in its board meeting on Monday, has announced to introduce uniform standards for nomination facilities and consistent norms for nominations across demat accounts and mutual fund investments. Here are the new rules explained
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418